A Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece

Clinical trial NCT02713295 · COMPLETED

Trial details

NCT number: NCT02713295
Sponsor: AbbVie
Status: COMPLETED
Study type: OBSERVATIONAL

Moderate to Severe Plaque Psoriasis

Start date: 2016-06-16
Primary completion: 2019-04-19
Enrollment: 273

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.